1. Home
  2. GLBS vs RVPH Comparison

GLBS vs RVPH Comparison

Compare GLBS & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Globus Maritime Limited

GLBS

Globus Maritime Limited

HOLD

Current Price

$2.15

Market Cap

35.0M

ML Signal

HOLD

Logo Reviva Pharmaceuticals Holdings Inc.

RVPH

Reviva Pharmaceuticals Holdings Inc.

HOLD

Current Price

$0.22

Market Cap

29.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GLBS
RVPH
Founded
2006
2006
Country
Greece
United States
Employees
N/A
14
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
35.0M
29.2M
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
GLBS
RVPH
Price
$2.15
$0.22
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
7
Target Price
$3.00
$3.14
AVG Volume (30 Days)
67.4K
2.5M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$24.03
N/A
Revenue Next Year
$13.92
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.00
$0.20
52 Week High
$2.12
$1.47

Technical Indicators

Market Signals
Indicator
GLBS
RVPH
Relative Strength Index (RSI) 68.96 29.12
Support Level $1.06 N/A
Resistance Level N/A $0.31
Average True Range (ATR) 0.14 0.02
MACD 0.04 -0.00
Stochastic Oscillator 100.00 15.18

Price Performance

Historical Comparison
GLBS
RVPH

About GLBS Globus Maritime Limited

Globus Maritime Ltd is a dry bulk shipping company that provides marine transportation services internationally. The company owns, operates, and manages a fleet of dry bulk vessels that transport iron ore, coal, grain, steel products, cement, alumina, and other dry bulk cargo. Its operations are managed by its subsidiary which also provides in-house commercial and technical management for its vessels and also offers consulting services for an affiliated ship management company. It generates maximum revenues by charging customers for the use of vessels to transport dry bulk commodities.

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.

Share on Social Networks: